Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies
Crossref DOI link: https://doi.org/10.1007/s11102-016-0742-1
Published Online: 2016-09-06
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fleseriu, Maria
Castinetti, Frederic
Funding for this research was provided by:
Strongbridge Biopharma
License valid from 2016-09-06